바이오마커 발견 아웃소싱 서비스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global biomarker discovery outsourcing services market size is expected to reach USD 89.19 Billion in 2034 from USD 17.84 Billion in 2025, growing at a CAGR of 19.58 during 2026-2034.This market is experiencing strong growth due to increasing demand for precision medicine, drug development, and advanced diagnostic solutions. Biomarker discovery outsourcing services help pharmaceutical, biotechnology, and research organizations identify biological indicators that support disease detection, treatment selection, and therapeutic monitoring. Rising investments in genomics, proteomics, and personalized healthcare are driving market expansion. Organizations are increasingly outsourcing biomarker research activities to access specialized expertise, advanced technologies, and cost-efficient development processes.

The growing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is creating substantial demand for biomarker-based research. Advances in molecular biology, artificial intelligence, and high-throughput screening technologies are accelerating biomarker identification and validation. Pharmaceutical companies are utilizing outsourcing services to streamline clinical trials and improve drug development success rates. Additionally, increasing collaboration between research institutions and contract research organizations is supporting market growth.

Future prospects remain highly favorable as precision medicine continues transforming healthcare delivery. Emerging technologies in multi-omics research and data analytics are expected to enhance biomarker discovery capabilities. Expanding investments in personalized therapeutics and companion diagnostics will create additional growth opportunities. As healthcare systems increasingly focus on targeted treatments and early disease detection, the biomarker discovery outsourcing services market is projected to experience sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

• Predictive Biomarkers
• Prognostic Biomarkers
• Safety Biomarkers
• Surrogate Endpoints
• Other Types

By Service

• Genomics Biomarker Services
• Proteomics Biomarker Services
• Bioinformatics Biomarker Services
• Other Biomarker Services

By Therapeutic Area

• Oncology
• Cardiology
• Neurology
• Autoimmune Diseases
• Other Therapeutic Areas

By End Use

• Pharmaceutical Companies
• Biotechnology Companies
• Other End Users

COMPANIES PROFILED

• Charles River Laboratories International Inc., LabCorp (Laboratory Corporation of, America Holdings), Eurofins Scientific, ICON plc, Parexel International Corporation, Evotec SE, Crown Bioscience, Bio-Rad Laboratories, Frontage Laboratories Inc., Almac Group Limited, Sino Biological, REPROCELL Inc., Selvita S.A., Proteome Sciences plc, Celerion

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Predictive Biomarkers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Prognostic Biomarkers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Safety Biomarkers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Surrogate Endpoints Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET: BY SERVICE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Service
• 5.2. Genomics Biomarker Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Proteomics Biomarker Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Bioinformatics Biomarker Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Biomarker Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Therapeutic Area
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Autoimmune Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Therapeutic Areas Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Service
  • 8.2.3 By Therapeutic Area
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Service
  • 8.3.3 By Therapeutic Area
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Service
  • 8.4.3 By Therapeutic Area
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Service
  • 8.5.3 By Therapeutic Area
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Service
  • 8.6.3 By Therapeutic Area
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Charles River Laboratories International Inc
  • 10.2.2 LabCorp (Laboratory Corporation Of America Holdings)
  • 10.2.3 Eurofins Scientific
  • 10.2.4 ICON Plc
  • 10.2.5 Parexel International Corporation
  • 10.2.6 Evotec SE
  • 10.2.7 Crown Bioscience
  • 10.2.8 Bio-Rad Laboratories
  • 10.2.9 Frontage Laboratories Inc
  • 10.2.10 Almac Group Limited
  • 10.2.11 Sino Biological
  • 10.2.12 REPROCELL Inc
  • 10.2.13 Selvita S.A
  • 10.2.14 Proteome Sciences Plc
  • 10.2.15 Celerion